These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4571142)

  • 1. Metabolism, anticholinergic effects, and therapeutic outcome of desmethylimipramine in depressive illness.
    Watt DC; Crammer JL; Elkes A
    Psychol Med; 1972 Nov; 2(4):397-405. PubMed ID: 4571142
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effect of imipramine and desipramine on some symptoms of depressive illness.
    Edwards G
    Br J Psychiatry; 1965 Sep; 111(478):889-97. PubMed ID: 5317860
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticholinergic activity of the tricyclic antidepressants desipramine and doxepin in nondepressed volunteers.
    Peterson GR; Blackwell B; Hostetler RM; Kuzma R; Adolphe A
    Commun Psychopharmacol; 1978; 2(2):145-50. PubMed ID: 668301
    [No Abstract]   [Full Text] [Related]  

  • 4. Antidepressant effects of desipramine adminstered in two dosage schedules.
    Mendels J; Schless AP
    Dis Nerv Syst; 1977 Apr; 38(4):249-51. PubMed ID: 321197
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticholinergic effects and plasma desipramine levels.
    Rudorfer MV; Young RC
    Clin Pharmacol Ther; 1980 Nov; 28(5):703-6. PubMed ID: 7438688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness.
    Mindham RH; Howland C; Shepherd M
    Psychol Med; 1973 Feb; 3(1):5-17. PubMed ID: 4571148
    [No Abstract]   [Full Text] [Related]  

  • 8. Catecholamine metabolism, depressive illness, and drug response.
    Maas JW; Fawcett JA; Dekirmenjian H
    Arch Gen Psychiatry; 1972 Mar; 26(3):252-62. PubMed ID: 4551050
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticholinergic activity of two tricyclic antidepressants.
    Blackwell B; Stefopoulos A; Enders P; Kuzma R; Adolphe A
    Am J Psychiatry; 1978 Jun; 135(6):722-4. PubMed ID: 655282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of anticholinergic effects of imipramine-like drugs.
    Vaillant GE
    Am J Psychiatry; 1969 May; 125(11):1600-2. PubMed ID: 5769289
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled study of desipramine in the treatment of hospitalized depressive disorders.
    Vestre ND; Janecek J; Zimmermann R
    Int J Neuropsychiatry; 1967 Aug; 3(4):354-9. PubMed ID: 4863508
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of desipramine on body weight in depression.
    Levitt AJ; Joffe RT; Esche I; Sherret D
    J Clin Psychiatry; 1987 Jan; 48(1):27-8. PubMed ID: 3804981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of depression. A comparative trial of imipramine and desipramine.
    Rose JT; Westhead TT
    Br J Psychiatry; 1967 Jun; 113(499):659-65. PubMed ID: 4863914
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose responses and relationships between anticholinergic activity and mood with tricyclic antidepressants.
    Blackwell B; Lipkin JO; Meyer JH; Kuzma R; Boulter WV
    Psychopharmacologia; 1972; 25(3):205-17. PubMed ID: 4557940
    [No Abstract]   [Full Text] [Related]  

  • 15. Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism.
    Muscettola G; Goodwin FK; Potter WZ; Claeys MM; Markey SP
    Arch Gen Psychiatry; 1978 May; 35(5):621-5. PubMed ID: 365126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications.
    Marshall JB; Forker AD
    Am Heart J; 1982 Mar; 103(3):401-14. PubMed ID: 7039280
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report.
    Puig-Antich J; Perel JM; Lupatkin W; Chambers WJ; Shea C; Tabrizi MA; Stiller RL
    J Am Acad Child Psychiatry; 1979; 18(4):616-27. PubMed ID: 541469
    [No Abstract]   [Full Text] [Related]  

  • 18. The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitriptyline and desipramine in human volunteers.
    Szabadi E; Gaszner P; Bradshaw CM
    Br J Psychiatry; 1980 Nov; 137():433-9. PubMed ID: 7470769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative trial of desipramine and nortriptyline in depression.
    Stewart JA; Mitchell PH
    Br J Psychiatry; 1968 Apr; 114(509):469-71. PubMed ID: 4872148
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical research on a new antidepressive drug (desipramine) and its comparison with imipramine].
    Vescovini L
    Riv Sper Freniatr Med Leg Alien Ment; 1969 Aug; 93(4):1010-31. PubMed ID: 4929207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.